Chelsea Counsel Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.8K | Hold |
150
| – | – | 0.03% | 127 |
|
|
2025
Q1 | $72.7K | Hold |
150
| – | – | 0.04% | 121 |
|
|
2024
Q4 | $60.4K | Hold |
150
| – | – | 0.03% | 125 |
|
|
2024
Q3 | $69.8K | Hold |
150
| – | – | 0.03% | 125 |
|
|
2024
Q2 | $70.3K | Buy |
+150
| New | +$70.3K | 0.04% | 118 |
|
|
2015
Q2 | – | Sell |
-2,300
| Closed | -$271K | – | 167 |
|
|
2015
Q1 | $271K | Hold |
2,300
| – | – | 0.06% | 115 |
|
|
2014
Q4 | $273K | Buy |
+2,300
| New | +$273K | 0.06% | 113 |
|